carcinoma papilífero familiar de tireóide - Faculdade de Medicina ...

susceptibility gene for familial nonmedullary thyroid carcinoma to
chromosome 2q21. Am J Hum Genet 2001; 69: 440–446.
59. McKay JD, Thompson D, Lesueur F, Stankov K, Pastore A, Watfah C, Strolz
S, Rickabona G, Moncayo R, Romeo G, Goldgar DE. Evidence for
interaction between the tco and nmtc1 loci in familial nonmedullary thyroid
cancer. J Med Genet 2004;41:407–412.
60. Lesueur F, Stark M, Tocco T, Ayadi H, Delisle MJ, Goldgar DE,
Schlumberger M, Romeo G, Canzian F. Genetic heterogeneity in familial
nonmedullary thyroid carcinoma: Exclusion of linkage to ret, mng1, and tco
in 56 families. Nmtc consortium. J Clin Endocrinol Metab 1999;84:2157–
2162.
61. Burgess JR, Duffield A, Wilkinson SJ, Ware R, Greenaway TM, Percival J,
Hoffman L. Two families with an autosomal dominant inheritance pattern for
papillary carcinoma of the thyroid. J Clin Endocrinol Metab 1997;82:345–
348.
62. Kazakov VS, Demidchik EP, Astakhova LN. Thyroid cancer after
chernobyl. Nature 1992;359:21.
63. Bounacer A, Wicker R, Caillou B, Cailleux AF, Sarasin A, Schlumberger M,
Suarez HG. High prevalence of activating ret proto-oncogene
rearrangements, in thyroid tumors from patients who had received external
radiation. Oncogene 1997;15:1263–1273.
64. Bacher-Stier C, Riccabona G, Totsch M, Kemmler G, Oberaigner W,
Moncayo R. Incidence and clinical characteristics of thyroid carcinoma after
iodine prophylaxis in an endemic goiter country. Thyroid 1997;7:733–741.
66